Huntington Disease Protein Market
1 Study Coverage
1.1 Huntington Disease Protein Product Introduction
1.2 Market by Type
1.2.1 Global Huntington Disease Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NI-302
1.2.3 NLF-HD
1.2.4 P-301905
1.2.5 IONIS-HTTRx
1.2.6 Others
1.3 Market by Application
1.3.1 Global Huntington Disease Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Alzheimer's Disease
1.3.3 Kennedy's Disease
1.3.4 Spinocerebellar Ataxia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Huntington Disease Protein Sales Estimates and Forecasts 2017-2028
2.2 Global Huntington Disease Protein Revenue Estimates and Forecasts 2017-2028
2.3 Global Huntington Disease Protein Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Huntington Disease Protein Sales by Region
2.4.1 Global Huntington Disease Protein Sales by Region (2017-2022)
2.4.2 Global Sales Huntington Disease Protein by Region (2023-2028)
2.5 Global Huntington Disease Protein Revenue by Region
2.5.1 Global Huntington Disease Protein Revenue by Region (2017-2022)
2.5.2 Global Huntington Disease Protein Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Huntington Disease Protein Sales by Manufacturers
3.1.1 Global Top Huntington Disease Protein Manufacturers by Sales (2017-2022)
3.1.2 Global Huntington Disease Protein Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Huntington Disease Protein in 2021
3.2 Global Huntington Disease Protein Revenue by Manufacturers
3.2.1 Global Huntington Disease Protein Revenue by Manufacturers (2017-2022)
3.2.2 Global Huntington Disease Protein Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Huntington Disease Protein Revenue in 2021
3.3 Global Huntington Disease Protein Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Huntington Disease Protein Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Huntington Disease Protein Sales by Type
4.1.1 Global Huntington Disease Protein Historical Sales by Type (2017-2022)
4.1.2 Global Huntington Disease Protein Forecasted Sales by Type (2023-2028)
4.1.3 Global Huntington Disease Protein Sales Market Share by Type (2017-2028)
4.2 Global Huntington Disease Protein Revenue by Type
4.2.1 Global Huntington Disease Protein Historical Revenue by Type (2017-2022)
4.2.2 Global Huntington Disease Protein Forecasted Revenue by Type (2023-2028)
4.2.3 Global Huntington Disease Protein Revenue Market Share by Type (2017-2028)
4.3 Global Huntington Disease Protein Price by Type
4.3.1 Global Huntington Disease Protein Price by Type (2017-2022)
4.3.2 Global Huntington Disease Protein Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Huntington Disease Protein Sales by Application
5.1.1 Global Huntington Disease Protein Historical Sales by Application (2017-2022)
5.1.2 Global Huntington Disease Protein Forecasted Sales by Application (2023-2028)
5.1.3 Global Huntington Disease Protein Sales Market Share by Application (2017-2028)
5.2 Global Huntington Disease Protein Revenue by Application
5.2.1 Global Huntington Disease Protein Historical Revenue by Application (2017-2022)
5.2.2 Global Huntington Disease Protein Forecasted Revenue by Application (2023-2028)
5.2.3 Global Huntington Disease Protein Revenue Market Share by Application (2017-2028)
5.3 Global Huntington Disease Protein Price by Application
5.3.1 Global Huntington Disease Protein Price by Application (2017-2022)
5.3.2 Global Huntington Disease Protein Price Forecast by Application (2023-2028)
6 North America
6.1 North America Huntington Disease Protein Market Size by Type
6.1.1 North America Huntington Disease Protein Sales by Type (2017-2028)
6.1.2 North America Huntington Disease Protein Revenue by Type (2017-2028)
6.2 North America Huntington Disease Protein Market Size by Application
6.2.1 North America Huntington Disease Protein Sales by Application (2017-2028)
6.2.2 North America Huntington Disease Protein Revenue by Application (2017-2028)
6.3 North America Huntington Disease Protein Market Size by Country
6.3.1 North America Huntington Disease Protein Sales by Country (2017-2028)
6.3.2 North America Huntington Disease Protein Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Huntington Disease Protein Market Size by Type
7.1.1 Europe Huntington Disease Protein Sales by Type (2017-2028)
7.1.2 Europe Huntington Disease Protein Revenue by Type (2017-2028)
7.2 Europe Huntington Disease Protein Market Size by Application
7.2.1 Europe Huntington Disease Protein Sales by Application (2017-2028)
7.2.2 Europe Huntington Disease Protein Revenue by Application (2017-2028)
7.3 Europe Huntington Disease Protein Market Size by Country
7.3.1 Europe Huntington Disease Protein Sales by Country (2017-2028)
7.3.2 Europe Huntington Disease Protein Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Huntington Disease Protein Market Size by Type
8.1.1 Asia Pacific Huntington Disease Protein Sales by Type (2017-2028)
8.1.2 Asia Pacific Huntington Disease Protein Revenue by Type (2017-2028)
8.2 Asia Pacific Huntington Disease Protein Market Size by Application
8.2.1 Asia Pacific Huntington Disease Protein Sales by Application (2017-2028)
8.2.2 Asia Pacific Huntington Disease Protein Revenue by Application (2017-2028)
8.3 Asia Pacific Huntington Disease Protein Market Size by Region
8.3.1 Asia Pacific Huntington Disease Protein Sales by Region (2017-2028)
8.3.2 Asia Pacific Huntington Disease Protein Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Huntington Disease Protein Market Size by Type
9.1.1 Latin America Huntington Disease Protein Sales by Type (2017-2028)
9.1.2 Latin America Huntington Disease Protein Revenue by Type (2017-2028)
9.2 Latin America Huntington Disease Protein Market Size by Application
9.2.1 Latin America Huntington Disease Protein Sales by Application (2017-2028)
9.2.2 Latin America Huntington Disease Protein Revenue by Application (2017-2028)
9.3 Latin America Huntington Disease Protein Market Size by Country
9.3.1 Latin America Huntington Disease Protein Sales by Country (2017-2028)
9.3.2 Latin America Huntington Disease Protein Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Huntington Disease Protein Market Size by Type
10.1.1 Middle East and Africa Huntington Disease Protein Sales by Type (2017-2028)
10.1.2 Middle East and Africa Huntington Disease Protein Revenue by Type (2017-2028)
10.2 Middle East and Africa Huntington Disease Protein Market Size by Application
10.2.1 Middle East and Africa Huntington Disease Protein Sales by Application (2017-2028)
10.2.2 Middle East and Africa Huntington Disease Protein Revenue by Application (2017-2028)
10.3 Middle East and Africa Huntington Disease Protein Market Size by Country
10.3.1 Middle East and Africa Huntington Disease Protein Sales by Country (2017-2028)
10.3.2 Middle East and Africa Huntington Disease Protein Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Corporation Information
11.1.2 AFFiRiS AG Overview
11.1.3 AFFiRiS AG Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AFFiRiS AG Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AFFiRiS AG Recent Developments
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Corporation Information
11.2.2 Ionis Pharmaceuticals, Inc. Overview
11.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ionis Pharmaceuticals, Inc. Recent Developments
11.3 Neurimmune Holding AG
11.3.1 Neurimmune Holding AG Corporation Information
11.3.2 Neurimmune Holding AG Overview
11.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Neurimmune Holding AG Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Neurimmune Holding AG Recent Developments
11.4 nLife Therapeutics, S.L.
11.4.1 nLife Therapeutics, S.L. Corporation Information
11.4.2 nLife Therapeutics, S.L. Overview
11.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 nLife Therapeutics, S.L. Recent Developments
11.5 reMYND NV
11.5.1 reMYND NV Corporation Information
11.5.2 reMYND NV Overview
11.5.3 reMYND NV Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 reMYND NV Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 reMYND NV Recent Developments
11.6 Sangamo BioSciences, Inc.
11.6.1 Sangamo BioSciences, Inc. Corporation Information
11.6.2 Sangamo BioSciences, Inc. Overview
11.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sangamo BioSciences, Inc. Recent Developments
11.7 UniQure N.V.
11.7.1 UniQure N.V. Corporation Information
11.7.2 UniQure N.V. Overview
11.7.3 UniQure N.V. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 UniQure N.V. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 UniQure N.V. Recent Developments
11.8 Voyager Therapeutics, Inc.
11.8.1 Voyager Therapeutics, Inc. Corporation Information
11.8.2 Voyager Therapeutics, Inc. Overview
11.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Voyager Therapeutics, Inc. Recent Developments
11.9 Vybion, Inc.
11.9.1 Vybion, Inc. Corporation Information
11.9.2 Vybion, Inc. Overview
11.9.3 Vybion, Inc. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vybion, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vybion, Inc. Recent Developments
11.10 WAVE Life Sciences Ltd.
11.10.1 WAVE Life Sciences Ltd. Corporation Information
11.10.2 WAVE Life Sciences Ltd. Overview
11.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 WAVE Life Sciences Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Huntington Disease Protein Industry Chain Analysis
12.2 Huntington Disease Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Huntington Disease Protein Production Mode & Process
12.4 Huntington Disease Protein Sales and Marketing
12.4.1 Huntington Disease Protein Sales Channels
12.4.2 Huntington Disease Protein Distributors
12.5 Huntington Disease Protein Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Huntington Disease Protein Industry Trends
13.2 Huntington Disease Protein Market Drivers
13.3 Huntington Disease Protein Market Challenges
13.4 Huntington Disease Protein Market Restraints
14 Key Findings in The Global Huntington Disease Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Huntington Disease Protein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of NI-302
Table 3. Major Manufacturers of NLF-HD
Table 4. Major Manufacturers of P-301905
Table 5. Major Manufacturers of IONIS-HTTRx
Table 6. Major Manufacturers of Others
Table 7. Global Huntington Disease Protein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Huntington Disease Protein Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Huntington Disease Protein Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Huntington Disease Protein Sales Market Share by Region (2017-2022)
Table 11. Global Huntington Disease Protein Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Huntington Disease Protein Sales Market Share by Region (2023-2028)
Table 13. Global Huntington Disease Protein Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Huntington Disease Protein Revenue Market Share by Region (2017-2022)
Table 15. Global Huntington Disease Protein Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Huntington Disease Protein Revenue Market Share by Region (2023-2028)
Table 17. Global Huntington Disease Protein Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Huntington Disease Protein Sales Share by Manufacturers (2017-2022)
Table 19. Global Huntington Disease Protein Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Huntington Disease Protein Revenue Share by Manufacturers (2017-2022)
Table 21. Huntington Disease Protein Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Huntington Disease Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Huntington Disease Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntington Disease Protein as of 2021)
Table 24. Huntington Disease Protein Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Huntington Disease Protein Product Offered
Table 26. Date of Manufacturers Enter into Huntington Disease Protein Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Huntington Disease Protein Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Huntington Disease Protein Sales Share by Type (2017-2022)
Table 31. Global Huntington Disease Protein Sales Share by Type (2023-2028)
Table 32. Global Huntington Disease Protein Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Huntington Disease Protein Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Huntington Disease Protein Revenue Share by Type (2017-2022)
Table 35. Global Huntington Disease Protein Revenue Share by Type (2023-2028)
Table 36. Huntington Disease Protein Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Huntington Disease Protein Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Huntington Disease Protein Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Huntington Disease Protein Sales Share by Application (2017-2022)
Table 41. Global Huntington Disease Protein Sales Share by Application (2023-2028)
Table 42. Global Huntington Disease Protein Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Huntington Disease Protein Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Huntington Disease Protein Revenue Share by Application (2017-2022)
Table 45. Global Huntington Disease Protein Revenue Share by Application (2023-2028)
Table 46. Huntington Disease Protein Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Huntington Disease Protein Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Huntington Disease Protein Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Huntington Disease Protein Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Huntington Disease Protein Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Huntington Disease Protein Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Huntington Disease Protein Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Huntington Disease Protein Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Huntington Disease Protein Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Huntington Disease Protein Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Huntington Disease Protein Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Huntington Disease Protein Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Huntington Disease Protein Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Huntington Disease Protein Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Huntington Disease Protein Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Huntington Disease Protein Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Huntington Disease Protein Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Huntington Disease Protein Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Huntington Disease Protein Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Huntington Disease Protein Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Huntington Disease Protein Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Huntington Disease Protein Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Huntington Disease Protein Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Huntington Disease Protein Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Huntington Disease Protein Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Huntington Disease Protein Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Huntington Disease Protein Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Huntington Disease Protein Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Huntington Disease Protein Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Huntington Disease Protein Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Huntington Disease Protein Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Huntington Disease Protein Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Huntington Disease Protein Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Huntington Disease Protein Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Huntington Disease Protein Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Huntington Disease Protein Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Huntington Disease Protein Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Huntington Disease Protein Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Huntington Disease Protein Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Huntington Disease Protein Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Huntington Disease Protein Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Huntington Disease Protein Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Huntington Disease Protein Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Huntington Disease Protein Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Huntington Disease Protein Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Huntington Disease Protein Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Huntington Disease Protein Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Huntington Disease Protein Revenue by Country (2023-2028) & (US$ Million)
Table 108. AFFiRiS AG Corporation Information
Table 109. AFFiRiS AG Description and Major Businesses
Table 110. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. AFFiRiS AG Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. AFFiRiS AG Recent Developments
Table 113. Ionis Pharmaceuticals, Inc. Corporation Information
Table 114. Ionis Pharmaceuticals, Inc. Description and Major Businesses
Table 115. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Ionis Pharmaceuticals, Inc. Recent Developments
Table 118. Neurimmune Holding AG Corporation Information
Table 119. Neurimmune Holding AG Description and Major Businesses
Table 120. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Neurimmune Holding AG Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Neurimmune Holding AG Recent Developments
Table 123. nLife Therapeutics, S.L. Corporation Information
Table 124. nLife Therapeutics, S.L. Description and Major Businesses
Table 125. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. nLife Therapeutics, S.L. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. nLife Therapeutics, S.L. Recent Developments
Table 128. reMYND NV Corporation Information
Table 129. reMYND NV Description and Major Businesses
Table 130. reMYND NV Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. reMYND NV Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. reMYND NV Recent Developments
Table 133. Sangamo BioSciences, Inc. Corporation Information
Table 134. Sangamo BioSciences, Inc. Description and Major Businesses
Table 135. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Sangamo BioSciences, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sangamo BioSciences, Inc. Recent Developments
Table 138. UniQure N.V. Corporation Information
Table 139. UniQure N.V. Description and Major Businesses
Table 140. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. UniQure N.V. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. UniQure N.V. Recent Developments
Table 143. Voyager Therapeutics, Inc. Corporation Information
Table 144. Voyager Therapeutics, Inc. Description and Major Businesses
Table 145. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 146. Voyager Therapeutics, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Voyager Therapeutics, Inc. Recent Developments
Table 148. Vybion, Inc. Corporation Information
Table 149. Vybion, Inc. Description and Major Businesses
Table 150. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Vybion, Inc. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Vybion, Inc. Recent Developments
Table 153. WAVE Life Sciences Ltd. Corporation Information
Table 154. WAVE Life Sciences Ltd. Description and Major Businesses
Table 155. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 156. WAVE Life Sciences Ltd. Huntington Disease Protein Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. WAVE Life Sciences Ltd. Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Huntington Disease Protein Distributors List
Table 161. Huntington Disease Protein Customers List
Table 162. Huntington Disease Protein Market Trends
Table 163. Huntington Disease Protein Market Drivers
Table 164. Huntington Disease Protein Market Challenges
Table 165. Huntington Disease Protein Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington Disease Protein Product Picture
Figure 3. Global Huntington Disease Protein Market Share by Type in 2021 & 2028
Figure 3. NI-302 Product Picture
Figure 4. NLF-HD Product Picture
Figure 5. P-301905 Product Picture
Figure 6. IONIS-HTTRx Product Picture
Figure 7. Others Product Picture
Figure 8. Global Huntington Disease Protein Market Share by Application in 2021 & 2028
Figure 9. Alzheimer's Disease
Figure 10. Kennedy's Disease
Figure 11. Spinocerebellar Ataxia
Figure 12. Others
Figure 13. Huntington Disease Protein Report Years Considered
Figure 14. Global Huntington Disease Protein Sales 2017-2028 (K Pcs)
Figure 15. Global Huntington Disease Protein Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Huntington Disease Protein Revenue 2017-2028 (US$ Million)
Figure 17. Global Huntington Disease Protein Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Huntington Disease Protein Sales Market Share by Region (2017-2022)
Figure 19. Global Huntington Disease Protein Sales Market Share by Region (2023-2028)
Figure 20. North America Huntington Disease Protein Sales YoY (2017-2028) & (K Pcs)
Figure 21. North America Huntington Disease Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Huntington Disease Protein Sales YoY (2017-2028) & (K Pcs)
Figure 23. Europe Huntington Disease Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Huntington Disease Protein Sales YoY (2017-2028) & (K Pcs)
Figure 25. Asia-Pacific Huntington Disease Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Huntington Disease Protein Sales YoY (2017-2028) & (K Pcs)
Figure 27. Latin America Huntington Disease Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Huntington Disease Protein Sales YoY (2017-2028) & (K Pcs)
Figure 29. Middle East & Africa Huntington Disease Protein Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Huntington Disease Protein Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Huntington Disease Protein in the World: Market Share by Huntington Disease Protein Revenue in 2021
Figure 32. Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Huntington Disease Protein Sales Market Share by Type (2017-2028)
Figure 34. Global Huntington Disease Protein Revenue Market Share by Type (2017-2028)
Figure 35. Global Huntington Disease Protein Sales Market Share by Application (2017-2028)
Figure 36. Global Huntington Disease Protein Revenue Market Share by Application (2017-2028)
Figure 37. North America Huntington Disease Protein Sales Market Share by Type (2017-2028)
Figure 38. North America Huntington Disease Protein Revenue Market Share by Type (2017-2028)
Figure 39. North America Huntington Disease Protein Sales Market Share by Application (2017-2028)
Figure 40. North America Huntington Disease Protein Revenue Market Share by Application (2017-2028)
Figure 41. North America Huntington Disease Protein Sales Share by Country (2017-2028)
Figure 42. North America Huntington Disease Protein Revenue Share by Country (2017-2028)
Figure 43. U.S. Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Huntington Disease Protein Sales Market Share by Type (2017-2028)
Figure 46. Europe Huntington Disease Protein Revenue Market Share by Type (2017-2028)
Figure 47. Europe Huntington Disease Protein Sales Market Share by Application (2017-2028)
Figure 48. Europe Huntington Disease Protein Revenue Market Share by Application (2017-2028)
Figure 49. Europe Huntington Disease Protein Sales Share by Country (2017-2028)
Figure 50. Europe Huntington Disease Protein Revenue Share by Country (2017-2028)
Figure 51. Germany Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 52. France Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Huntington Disease Protein Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Huntington Disease Protein Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Huntington Disease Protein Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Huntington Disease Protein Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Huntington Disease Protein Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Huntington Disease Protein Revenue Share by Region (2017-2028)
Figure 62. China Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 65. India Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Huntington Disease Protein Sales Market Share by Type (2017-2028)
Figure 73. Latin America Huntington Disease Protein Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Huntington Disease Protein Sales Market Share by Application (2017-2028)
Figure 75. Latin America Huntington Disease Protein Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Huntington Disease Protein Sales Share by Country (2017-2028)
Figure 77. Latin America Huntington Disease Protein Revenue Share by Country (2017-2028)
Figure 78. Mexico Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Huntington Disease Protein Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Huntington Disease Protein Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Huntington Disease Protein Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Huntington Disease Protein Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Huntington Disease Protein Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Huntington Disease Protein Revenue Share by Country (2017-2028)
Figure 87. Turkey Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Huntington Disease Protein Revenue (2017-2028) & (US$ Million)
Figure 90. Huntington Disease Protein Value Chain
Figure 91. Huntington Disease Protein Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
Industry Market Size
